Beleave Inc. (BLEVF) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 18, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerBeleave Inc. (BLEVF) trades at $0.000001. Beleave Inc. is a Canadian medical cannabis company involved in cultivation, sales, and clinic operations. The company faces challenges in a competitive market with a negative profit margin. Sector: Healthcare.
Price as of · Last analyzed: Mar 18, 2026Analyst Coverage for BLEVF: BLEVF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
Beleave Inc. (BLEVF) Healthcare & Pipeline Overview
Beleave Inc., based in Canada, cultivates and sells medical and recreational cannabis, operating Medi-Green clinics in Ontario and Quebec. With a negative profit margin of -1423.0% and trading on the OTC market, the company navigates a competitive landscape against peers like ACGJ and ARTH.
What Is the Investment Thesis for BLEVF?
Investing in Beleave Inc. (BLEVF) presents a speculative opportunity within the Canadian cannabis market. Key value drivers include the potential expansion of its Medi-Green clinic network and increased sales of recreational cannabis products. However, the company's negative profit margin of -1423.0% raises concerns about its financial sustainability. Growth catalysts include potential regulatory changes that could expand market access and increased consumer demand for cannabis products. The company's high beta of -148.45 indicates extreme volatility relative to the market. The investment thesis hinges on Beleave's ability to improve its operational efficiency, reduce costs, and achieve profitability in a highly competitive environment. Investors should carefully consider the risks associated with investing in a company with a history of financial losses and significant market volatility.
Based on FMP financials and quantitative analysis
BLEVF Key Highlights
Negative Profit Margin: Beleave Inc. has a profit margin of -1423.0%, indicating significant losses relative to revenue.
- Gross Margin: The company's gross margin is 34.4%, suggesting some efficiency in production costs before accounting for operating expenses.
- Market Cap: Beleave Inc.'s market capitalization is $0.00B, reflecting its small size and potential risks.
- P/E Ratio: The company's P/E ratio is -0.00, which is not meaningful due to negative earnings.
- Beta: Beleave Inc. has a beta of -148.45, indicating extreme volatility and a negative correlation with the market.
Who Are BLEVF's Competitors?
BLEVF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| AKAN Akanda Corp. | $1.98 | -10.41% | — | |
| SNOA Sonoma Pharmaceuticals, Inc. | $1.24 | -0.80% | $5.94M | — |
| BFRI Biofrontera Inc. | $1.01 | -2.40% | $13.0M | — |
| COSM COSM | $0.38 | -1.58% | $20.7M | — |
| QNTM Quantum BioPharma Ltd. | $3.44 | +0.44% | $22.0M | — |
| AYTU Aytu BioPharma, Inc. | $2.07 | -0.96% | $22.2M | — |
| TXMD TherapeuticsMD, Inc. | $2.05 | +0.99% | $23.7M | — |
| CPHI CPHI | $0.66 | +0.61% | $26.6M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are BLEVF's Key Strengths?
Established network of medical cannabis clinics.
- Integrated business model.
- Brand recognition in the Canadian market.
What Are BLEVF's Weaknesses?
Negative profit margin.
- High beta indicating extreme volatility.
- Small market capitalization.
What Are the Key Risks for BLEVF?
Financial-distress signal — its Altman Z-Score of -5.63 sits in the distress zone (elevated bankruptcy risk).
- Intense competition in the Canadian cannabis market.
- Fluctuations in cannabis prices.
- Evolving regulations.
- Negative profit margin and financial losses.
- Low liquidity due to OTC market trading.
What Are BLEVF's Competitive Advantages?
- Established network of Medi-Green medical cannabis clinics.
- Integrated business model encompassing cultivation, retail, and clinic operations.
- Brand recognition in the Canadian cannabis market.
What Does BLEVF Do?
Beleave Inc. was founded to participate in the burgeoning Canadian cannabis market, focusing on both medical and recreational applications. The company cultivates cannabis and manufactures related products, selling them through its own retail stores and online platforms. Additionally, Beleave operates a network of medical cannabis clinics under the Medi-Green banner in Ontario and Quebec, providing patient access and education. The company's business model integrates cultivation, product development, retail, and clinic operations to serve a broad spectrum of cannabis consumers and patients. Beleave Inc. is headquartered in Oakville, Canada, and has sought to establish a presence across the Canadian market. However, the company faces challenges in achieving profitability, as reflected in its significant negative profit margin. Beleave competes with other cannabis producers and retailers, striving to differentiate itself through product quality, clinic services, and brand recognition. The company's strategy involves expanding its product offerings and clinic network to capture a larger share of the Canadian cannabis market. Beleave aims to capitalize on the growing acceptance and legalization of cannabis in Canada, while navigating regulatory complexities and competitive pressures.
What Products and Services Does BLEVF Offer?
- Cultivates medical and recreational cannabis.
- Sells cannabis products through retail stores.
- Operates an online platform for cannabis sales.
- Manages a network of medical cannabis clinics under the Medi-Green banner.
- Provides patient access and education through its clinics.
- Manufactures cannabis-related products.
How Does BLEVF Make Money?
- Cultivating cannabis and processing it into various products.
- Selling cannabis products directly to consumers through retail stores and online.
- Generating revenue from patient consultations and cannabis prescriptions through Medi-Green clinics.
What Industry Does BLEVF Operate In?
Beleave Inc. operates within the Canadian cannabis industry, which has experienced rapid growth and increasing competition since legalization. The market is characterized by evolving regulations, shifting consumer preferences, and the emergence of numerous players vying for market share. Companies like Beleave face the challenge of differentiating themselves in a crowded market while navigating complex regulatory frameworks. The industry is also subject to fluctuations in cannabis prices and changing consumer demand patterns. Beleave competes with larger, more established cannabis companies, as well as smaller, niche players. The company's success depends on its ability to innovate, execute its business strategy effectively, and adapt to the dynamic market environment.
Who Are BLEVF's Key Customers?
- Medical cannabis patients seeking therapeutic relief.
- Recreational cannabis consumers.
- Individuals seeking cannabis-related information and education.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Company Profile
Beleave Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Oakville, CA. The company is led by CEO Vasilios Panagiotakopoulos. BLEVF has traded publicly since 2016.
Financial Health
Beleave Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -5.63 places it in the distress zone, a signal of elevated financial risk.
BLEVF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
BLEVF Latest News
-
Stocks That Hit 52-Week Lows On Wednesday
· Nov 27, 2019
-
Stocks That Hit 52-Week Lows On Friday
· Oct 4, 2019
-
There's A New Cannabis Index To Help Investors Measure The Industry
· Jun 27, 2019
BLEVF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for BLEVF.
Price Targets
Wall Street price target analysis for BLEVF.
BLEVF MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for BLEVF; grades run from A+ (80-100) to F (below 30).
Leadership: Vasilios Panagiotakopoulos
CEO
Vasilios Panagiotakopoulos serves as the CEO of Beleave Inc. As CEO, he is responsible for overseeing the company's operations, strategic direction, and financial performance. His leadership is crucial for navigating the competitive Canadian cannabis market and achieving the company's growth objectives.
Track Record: Due to limitations in the provided data, it is not possible to assess Vasilios Panagiotakopoulos's specific achievements or strategic decisions as CEO of Beleave Inc. His track record and the company's milestones under his leadership are currently unknown.
BLEVF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Beleave Inc. may not meet the minimum financial standards or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial information available and may be subject to greater risks due to less stringent listing requirements. Investing in companies on the OTC Other tier requires careful due diligence and a thorough understanding of the associated risks, as these companies may not be subject to the same regulatory oversight as those listed on major exchanges.
- OTC Tier: OTC Other
- Limited financial disclosure due to OTC Other tier status.
- Low trading volume and liquidity.
- Potential for price manipulation.
- Higher risk of fraud or mismanagement compared to listed companies.
- Limited regulatory oversight.
- Verify the company's registration and legal standing.
- Obtain and review available financial statements.
- Assess the company's business model and competitive landscape.
- Evaluate the management team's experience and track record.
- Understand the company's capital structure and ownership.
- Assess the liquidity and trading volume of the stock.
- Consult with a qualified financial advisor.
- Operation of Medi-Green medical cannabis clinics.
- Cultivation and sale of cannabis products.
- Presence in the Canadian cannabis market.
What Investors Ask About Beleave Inc. (BLEVF) — Healthcare
What does Beleave Inc. do?
Beleave Inc. operates as a medical cannabis company in Canada. It cultivates and sells both medical and recreational cannabis products through its own retail stores and online platform.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Limited financial information available for Beleave Inc.
- Lack of analyst coverage for BLEVF stock.
- OTC listing indicates higher risk and lower liquidity.